NYU Langone experts join global leaders in San Diego for the 2025 annual meeting of the American Academy of Neurology, fostering innovation, education, and collaboration.

Below are highlights from more than 70 presentations featuring NYU Langone physicians and researchers. For a full list of presentations, visit the AAN website.

Saturday, April 5

Seminar
C16 – Revised McDonald Criteria (2024): Diagnosis and Misdiagnosis of MS in 2024 and Beyond
Title: The Optic Nerve in MS: A New Addition
Presenter: Laura J. Balcer, MD
Time: 12:45AM–1:05PM
Location: 29CD

Sunday, April 6

Scientific Platform Session
S3 – Multiple Sclerosis: Clinical Trials
Abstract Title: Association of Social Determinants of Health with Brain MRI Outcomes in Individuals with Pediatric Onset Multiple Sclerosis
NYU Langone Authors: Lauren B. Krupp, MD
Time: 1:24–1:36PM
Location: 30C-E

Seminar
Neurology Education (Reverse) Shark Tank
Moderator: Steven L. Galetta, MD
Time: 3:30–5:30PM
Location: 28A-C

Monday, April 7

Scientific Platform Session
S17 – Neurocritical Care
Abstract Title: Intensive BP Reduction by 90 Minutes is Associated with Decreased Hematoma Expansion After Spontaneous ICH
NYU Langone Authors: Jennifer A. Frontera, MD; Kara R. Melmed, MD
Time: 1:48–2:00PM
Location: 25A

Panel Discussion
C121 – Neurology Education: A. B. Baker Showcase: Successful Programs, Activities, and Structural Changes to Address Learner and Faculty Wellness
Presenters: Niel A. Busis, MD; Arielle M. Kurzweil, MD
Time: 2:00–3:00PM
Location: 28A-C

Hubs (HeadTalks)
H90 – The Art of the Ask: Fundraising in Neurology (HeadTalks)
Presenter: Steven L. Galetta, MD
Time: 2:13–3:00PM
Location: D Lobby

Tuesday, April 8

Seminar
C135 – Treatment of Pediatric Multiple Sclerosis in the Current Era
Title: Pediatric MS: Causes and Consequence from an Ecological and Psychosocial Perspective
Presenter: Lauren B. Krupp, MD
Time: 7:50–8:35AM
Location: 6A

Plenary Session
PL5 – Clinical Trials Plenary Session
Title: The Phase 3 PROOF-HD Trial Demonstrates Meaningful Benefits of Pridopidine on Function, Cognition, and Motor Signs in Huntington Disease (HD)
Presenter: Andrew S. Feigin, MD
Time: 9:15–9:30AM
Location: Ballroom 20

Seminar
C146 – Neuro-ophthalmology 2: Optic Neuritis, Visual Fields, and Anisocoria
Title: Management of Optic Neuritis
Presenter: Steven L. Galetta, MD
Time: 1:10–1:30PM
Location: 30C–E

Scientific Platform Session
S23 – Innovations in Dementia Treatment
Abstract Title: Early Clinical Outcomes Following Lecanemab Therapy for Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease
NYU Langone Authors: Arjun V. Masurkar, MD; Martin Sadowski, MD, PhD; Thomas M. Wisniewski, MD
Time: 1:12–1:24PM
Location: 4

Scientific Platform Session
S25 – Emerging Stroke Therapies and Risk Stratification
Moderator: Kara R. Melmed, MD
Time: 2:00–3:00PM
Location: 4

Wednesday, April 9

Hubs (HeadTalks)
H211 – Standing on the Shoulders of Giants (HeadTalks)
Presenter: Steven L. Galetta, MD
Time: 2:13–3:00PM
Location: D Lobby